The collaboration revenue of Intellia therapeutics in 2023 was 36.3 million U.S. dollars. Intellia Therapeutics is a U.S.-based biotech company focusing on the development of therapeutics using CRISPR technology.
Revenue of Intellia Therapeutics from 2015 to 2023
(in million U.S. dollars)
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
Intellia Therapeutics. (February 22, 2024). Revenue of Intellia Therapeutics from 2015 to 2023 (in million U.S. dollars) [Graph]. In Statista. Retrieved July 22, 2024, from https://www.statista.com/statistics/1097393/revenue-for-intellia-therapeutics/
Intellia Therapeutics. "Revenue of Intellia Therapeutics from 2015 to 2023 (in million U.S. dollars)." Chart. February 22, 2024. Statista. Accessed July 22, 2024. https://www.statista.com/statistics/1097393/revenue-for-intellia-therapeutics/
Intellia Therapeutics. (2024). Revenue of Intellia Therapeutics from 2015 to 2023 (in million U.S. dollars). Statista. Statista Inc.. Accessed: July 22, 2024. https://www.statista.com/statistics/1097393/revenue-for-intellia-therapeutics/
Intellia Therapeutics. "Revenue of Intellia Therapeutics from 2015 to 2023 (in Million U.S. Dollars)." Statista, Statista Inc., 22 Feb 2024, https://www.statista.com/statistics/1097393/revenue-for-intellia-therapeutics/
Intellia Therapeutics, Revenue of Intellia Therapeutics from 2015 to 2023 (in million U.S. dollars) Statista, https://www.statista.com/statistics/1097393/revenue-for-intellia-therapeutics/ (last visited July 22, 2024)
Revenue of Intellia Therapeutics from 2015 to 2023 (in million U.S. dollars) [Graph], Intellia Therapeutics, February 22, 2024. [Online]. Available: https://www.statista.com/statistics/1097393/revenue-for-intellia-therapeutics/
